Cytek Biosciences, Inc. (CTKB)

Acerca de Cytek Biosciences, Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Al 3 de noviembre de 2026, la acción de Cytek Biosciences, Inc. (CTKB) subió con fuerza a $6.04, un alza de 4.59% (+$0.27) frente al cierre anterior. En la sesión, las acciones han operado entre $5.77 y $6.09. Eso ubica a CTKB cerca del máximo de su rango de 52 semanas, de $3.31 a $6.33. Cytek Biosciences, Inc. opera en el sector de laboratory analytical instruments y tiene una capitalización de mercado de aproximadamente $750.00 millones, con cerca de 366.3 mil acciones negociadas.

Últimas noticias de CTKB

• Cytek Biosciences to Participate in Upcoming Investor ConferencesYahoo Finance· 29 oct, 4:30 p.m. ET
• Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseYahoo Finance· 29 oct, 9:00 a.m. ETNVAX
• Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out forYahoo Finance· 28 oct, 9:00 a.m. ET
• Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh ProfitabilityYahoo Finance· 24 oct, 8:14 p.m. ET
• Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026Yahoo Finance· 21 oct, 4:05 p.m. ET
• Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining ProfitabilityYahoo Finance· 29 sep, 10:14 a.m. ET
• Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis ToolYahoo Finance· 23 sep, 5:00 p.m. ET
• Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?Yahoo Finance· 17 sep, 8:48 a.m. ET

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de CTKB en un solo lugar? Crea una cuenta gratis →

• $CTKB Cytek Biosciences options open interest rises in focus this week https://www.macroaxis.com/stock-options/CTKB/Cytek-Biosciences?utm_source=dlvr.it&utm_medium=stocktwits

  @macroaxis· 2 oct, 8:15 p.m. ET

• 14 #stockbreakouts $CTKB, $EMCS, $PGRO, $PS, $RSKD, $VKTX (gap). Two sub-$1, one $1-2.

  @fallondpicks· 22 sep, 6:26 p.m. ET

• $CTKB let’s bang bro. ONTA 🐒🍌🧠⏰♾️

  @Doozio· 17 sep, 7:52 p.m. ET· Alcista

• https://www.marketbeat.com/earnings/reports/2026-8-5-cytek-biosciences-inc-stock/ $CTKB Cytek Biosciences Earnings Transcript

  @EarningsInsider· 5 ago, 5:31 p.m. ET

• $CTKB Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 down -125.00% YoY • Reported revenue of $48.14M up 5.57% YoY • Cytek Biosciences is updating its revenue outlook for the full year 2026 to be in the range of $207 million to $212 million, raising the m…

  @StocktwitsEarnings· 5 ago, 4:29 p.m. ET

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →